InvestorsHub Logo
Followers 34
Posts 6200
Boards Moderated 0
Alias Born 07/05/2004

Re: None

Tuesday, 12/05/2017 6:15:01 AM

Tuesday, December 05, 2017 6:15:01 AM

Post# of 12412
Current trial led by Shapiro, looks like this could be the trial where AAGP is being or will be tested on...

From our latest update:
3. Normothermic Liver Perfusion (start date to be determined)

Normothermic (body temperature), ex vivo (outside the body) liver perfusion (method of irrigation) is an innovative therapy applied to donor livers outside of the body before transplantation that improves organ quality and makes organs that were previously unsuitable safe for transplant.

Our planned testing is to determine the beneficial effects of adding AAGP™ to the perfusate solution. Perfusate solutions are used to protect donor organs from the period of harvest until transplantation. We hope to evidence that AAGP™ can extend the viable life of harvested transplant organs.

Now look at the trial descriptions:

https://clinicaltrials.gov/ct2/show/NCT03089840